-+ 0.00%
-+ 0.00%
-+ 0.00%

Xylem Affirms FY2026 Adj EPS Guidance of $5.55-$5.70 vs $5.54 Est; Affirms FY2026 Sales Guidance of $9.200B vs $9.254B Est

Benzinga·08/18/2026 14:56:23
Listen to the news
Xylem (NYSE:XYL) affirms FY2026 Adj EPS guidance from $5.55-$5.70 to $5.55-$5.70 vs $5.54 analyst estimate. Affirms FY2026 sales outlook from $9.200 billion to $9.200 billion vs $9.254 billion estimate.